Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

ALLOCATIONS OUT: NTT Finance Corp €3.85bn & £400m 6-part Sr Unsec; 3m€+45 / MS+60 / MS+80 / MS+100 / MS+123 & G+80

IGC European Market: Deal Flow - General

Issuer

Term

Maturity

Size

Ranking

Type

IPT

Spread Set

ISIN

NTT Finance Corp

2yr

20-Jun-28

€750m

Sr Unsec

Floating

3m€+70a

3m€+45

144A: XS3422221021 / RegS: XS3422220999

NTT Finance Corp

L3yr

01-Nov-29

€750m

Sr Unsec

Fixed

MS+85-90

MS+60

144A: XS3422221377 / RegS: XS3422221294

NTT Finance Corp

L5yr

01-Nov-31

€750m

Sr Unsec

Fixed

MS+105a

MS+80

144A: XS3422221534 / RegS: XS3422221450

NTT Finance Corp

8yr

01-Jul-34

€750m

Sr Unsec

Fixed

MS+125a

MS+100

144A: XS3422221708 / RegS: XS3422221617

NTT Finance Corp

L12yr

01-Nov-38

€850m

Sr Unsec

Fixed

MS+150a

MS+123

144A: XS3422221963 / RegS: XS3422221880

NTT Finance Corp

S3yr

29-Mar-29

£400m

Sr Unsec

Fixed

G+100a

G+80

144A: XS3422222185 / RegS: XS3422222003


2yr FRN: Final Books €1.4bn. Peak book €1.5bn.
L3yr: Final Books €1.4bn. Peak book €1.65bn.
L5yr: Final Books €1.5bn. Peak book €1.9bn.
8yr: Final Books €1.3bn. Peak book €1.75bn.
L12yr: Final Books €2.4bn. Peak book €2.55bn.
S3yr: Final Books £1.1bn. Peak book £1.2bn.

Launched:
2yr FRN: €750m @ 3m€+45bp - Books €1.5bn
L3yr: €750m @ MS+60bp - Books €1.65bn
L5yr: €750m @ MS+80bp - Books €1.9bn
8yr: €750m @ MS+100bp - Books €1.75bn
L12yr: €850m @ MS+123bp - Books €2.55bn
S3yr: £400m @ G+80bp - Books £1.2bn

IPTs: 2yr FRN: 3m€+70a L3yr: MS+85-90bp L5yr: MS+105a 8yr: MS+125a L12yr: MS+150a S3yr: G+100a


  • Issuer: NTT Finance Corporation (Ticker: NTT, Country: Japan)
  • Issuer LEI: 3538007PR116187GD960
  • Expected Issue Ratings: A3/BBB+ (Moody's/S&P)
  • Ranking: Senior Unsecured
  • Format: 144A and 3(c)(7) / Reg S
  • Settlement Date: 01-Jul-26 (T+5)
  • Size:
    • 2yr FRN: €750m
    • L3yr: €750m
    • L5yr: €750m
    • 8yr: €750m
    • L12yr: €850m
    • S3yr: £400m
  • Maturity:
    • 2yr FRN: 20-Jun-28
    • L3yr: 01-Nov-29
    • L5yr: 01-Nov-31
    • 8yr: 01-Jul-34
    • L12yr: 01-Nov-38
    • S3yr: 29-Mar-29
  • Reference Benchmark:
    • 2yr FRN: n/a
    • L3yr: OBL 2.5% 10/29 (HR 100%)
    • L5yr: DBR 0% 8/31 (HR 109%)
    • 8yr: DBR 2.2% 2/34 (HR 102%)
    • L12yr: DBR 1% 5/38 (HR 109%)
    • S3yr: UKT 0.5% 1/29 (HR 110%)
  • Coupon:
    • 2yr FRN: Quarterly
    • L3yr: Fixed, Ann, Short 1st
    • L5yr: Fixed, Ann, Short 1st
    • 8yr: Fixed, Ann
    • L12yr: Fixed, Ann, Short 1st
    • S3yr: Fixed, S/A, Short 1st Cpn
  • Day Count:
    • 2yr FRN: Act/360
    • L3yr: ACT/ACT (ICMA)
    • L5yr: ACT/ACT (ICMA)
    • 8yr: ACT/ACT (ICMA)
    • L12yr: ACT/ACT (ICMA)
    • S3yr: ACT/ACT (ICMA)
  • MWC:
    • 2yr FRN: n/a
    • L3yr: Yes, B+[ ]
    • L5yr: Yes, B+[ ]
    • 8yr: Yes, B+[ ]
    • L12yr: Yes, B+[ ]
    • S3yr: Yes, G+[ ]
  • Par Call:
    • 2yr FRN: n/a
    • L3yr: n/a
    • L5yr: 1m
    • 8yr: 2m
    • L12yr: 3m
    • S3yr: n/a
  • ISIN (144A):
    • 2yr FRN: XS3422221021
    • L3yr: XS3422221377
    • L5yr: XS3422221534
    • 8yr: XS3422221708
    • L12yr: XS3422221963
    • S3yr: XS3422222185
  • ISIN (RegS):
    • 2yr FRN: XS3422220999
    • L3yr: XS3422221294
    • L5yr: XS3422221450
    • 8yr: XS3422221617
    • L12yr: XS3422221880
    • S3yr: XS3422222003
  • Documentation: 144A/RegS, Standalone Prospectus / SGX-ST Listing / 100k+1k denoms
  • Sales into Canada: Yes
  • Use of Proceeds: General corporate purposes, including repayment of debt
  • Joint Bookrunners: JPM (B&D), Citi, BofA, MS, BNPP, GS, Barc, Mizuho, SMBC, Nomura, Daiwa
  • DealRoadshow: https://dealroadshow.com | Entry code: NTT2026 (not case sensitive)
  • Books Subject: Books subject at 12.45 UKT / 13.45 CET (Will be flex for US-based demand)
  • Hedge Deadline: 15.55 UKT / 16.55 CET
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.